|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,110 KRW | -.--% |
|
-4.01% | -27.08% |
EyeGene Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was KRW 3.6 million compared to KRW 3.15 million a year ago. Net loss was KRW 25,953.11 million compared to KRW 34,568.96 million a year ago.
Basic loss per share from continuing operations was KRW 1,210 compared to KRW 1,971 a year ago. Basic loss per share was KRW 1,210 compared to KRW 1,971 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.08% | 60.74M | |
| +32.86% | 704B | |
| +28.59% | 577B | |
| -3.76% | 348B | |
| +18.30% | 327B | |
| +5.47% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.05% | 147B |
EYEGENE INC. 
